Mannose-binding lectin and mannose-binding protein-associated serine protease 2 levels and infection in very-low-birth-weight infants

被引:5
作者
Hartz, Annika [1 ,2 ]
Schreiter, Lena [1 ,2 ]
Pagel, Julia [1 ,3 ]
Moser, Katja [4 ]
Wieg, Christian [4 ]
Grotheer, Anneke [1 ]
Rupp, Jan [3 ]
Herting, Egbert [1 ]
Goepel, Wolfgang [1 ]
Haertel, Christoph [1 ]
机构
[1] Univ Hosp Lubeck, Dept Pediat, Lubeck, Germany
[2] Univ Hosp Lubeck, Inst Syst Inflammat Res, Lubeck, Germany
[3] Univ Hosp Lubeck, Dept Clin Infect Dis & Microbiol, Lubeck, Germany
[4] Childrens Hosp Aschaffenburg Alzenau, Aschaffenburg, Germany
关键词
LARGE COHORT; COMPLEMENT; PATHWAY; SEPSIS; POLYMORPHISMS; IMMUNITY; CHILDREN;
D O I
10.1038/s41390-018-0017-9
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
OBJECTIVE: The aim of this study was to explore the role of the lectin pathway in neonatal sepsis through the study of MBL and MASP2 levels and their relationship with infection in a cohort of very-low-birth-weight infants (VLBWI). METHODS: MBL and MASP2 were measured in plasma samples of n = 89 VLBWI using ELISA and correlated with clinical parameters. MBL plasma levels were aligned with genotyping data of mb12 exon 1 polymorphisms, rs1800450, rs1800451, and rs5030737. RESULTS: MBL levels were clearly determined by MBL genotype, i.e., AA individuals had tenfold higher MBL levels than AO individuals. MBL and MASP2 levels did not correlate with gestational age, apart from MASP2 levels on day 7. During the first 21 days of life, we noted a gradual increase in both MBL and MASP2 levels. On day 7 of life, MASP2 levels in infants developing late-onset sepsis measured before the onset of symptoms were found to be lower, as compared to non-LOS infants. CONCLUSIONS: In our cohort of VLBWI, MBL levels were genetically determined, but not associated with gestational age or sepsis in the first 21 days of life. Lower MASP2 levels on day 7 may indicate increased risk for late-onset infection.
引用
收藏
页码:134 / 138
页数:5
相关论文
共 12 条
[1]   Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system [J].
Cedzynski, M ;
Szemraj, J ;
Swierzko, AS ;
Bak-Romaniszyn, L ;
Banasik, M ;
Zeman, K ;
Kilpatrick, DC .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 136 (02) :304-311
[2]   Ontogeny of early life immunity [J].
Dowling, David J. ;
Levi, Ofer .
TRENDS IN IMMUNOLOGY, 2014, 35 (07) :299-310
[3]   Mannose-binding lectin and its genetic variants [J].
Garred, P ;
Larsen, F ;
Seyfarth, J ;
Fujita, R ;
Madsen, HO .
GENES AND IMMUNITY, 2006, 7 (02) :85-94
[4]   Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome [J].
Garred, P ;
Strom, JJ ;
Quist, L ;
Taaning, E ;
Madsen, HO .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (09) :1394-1403
[5]   Mannose-binding lectin polymorphisms in severe sepsis: Relationship to levels, incidence, and outcome [J].
Gordon, AC ;
Waheed, U ;
Hansen, TK ;
Hitman, GA ;
Garrard, CS ;
Turner, MW ;
Klein, NJ ;
Brett, SJ ;
Hinds, CJ .
SHOCK, 2006, 25 (01) :88-93
[6]  
Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x
[7]   Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study [J].
Neth, O ;
Hann, I ;
Turner, MW ;
Klein, NJ .
LANCET, 2001, 358 (9282) :614-618
[8]   Higher Cord Blood Levels of Mannose-Binding Lectin-Associated Serine Protease-2 in Infants With Necrotising Enterocolitis [J].
Schlapbach, Luregn J. ;
Aebi, Christoph ;
Fisch, Urs ;
Ammann, Roland A. ;
Otth, Margrith ;
Bigler, Susanne ;
Nelle, Mathias ;
Berger, Steffen ;
Kessler, Ulf .
PEDIATRIC RESEARCH, 2008, 64 (05) :562-566
[9]   Differential Role of the Lectin Pathway of Complement Activation in Susceptibility to Neonatal Sepsis [J].
Schlapbach, Luregn J. ;
Mattmann, Maika ;
Thiel, Steffen ;
Boillat, Colette ;
Otth, Margrith ;
Nelle, Mathias ;
Wagner, Bendicht ;
Jensenius, Jens C. ;
Aebi, Christoph .
CLINICAL INFECTIOUS DISEASES, 2010, 51 (02) :153-162
[10]   Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2 [J].
Selander, B ;
Mårtensson, U ;
Weintraub, A ;
Holmström, E ;
Matsushita, M ;
Thiel, S ;
Jensenius, JC ;
Truedsson, L ;
Sjöholm, AG .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (05) :1425-1434